CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...